Smiths releases normal viewing implantable ports

Smiths Medical has introduced new implantable ports with CT identifiers intended for easy viewing with x-rays or CT scout scans.

Smiths' Port-a-Cath and P.A.S. Port Power P.A.C. enable power injections of contrast for CT, as well as long-term delivery of medications, such as for patients undergoing chemotherapy. According to Smiths, the top of each port now includes an easy-to-see CT identifier, so that the radiopaque letters "CT" can be read normally (rather than backwards) under scout scans.

The Ashford, U.K.-based Smiths manufactures specialist medical devices and equipment, focusing on medication delivery, vital care and safety devices.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.